Stay updated on Efgartigimod SC in Bullous Pemphigoid: Clinical Trial
Sign up to get notified when there's something new on the Efgartigimod SC in Bullous Pemphigoid: Clinical Trial page.

Latest updates to the Efgartigimod SC in Bullous Pemphigoid: Clinical Trial page
- Check3 days agoChange DetectedAdded Results Submitted and Locations sections to the study page, including state-level site listings (Arizona, California, Florida, Michigan, Missouri, Ohio). Updated to Revision: v3.3.3.SummaryDifference0.6%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check33 days agoChange DetectedRevision tag updated from v3.2.0 to v3.3.2 on the study page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check40 days agoChange DetectedThe page deleted a government-funding notice about potential delays and operating status, which is a site-wide notice rather than study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check61 days agoChange DetectedNo additions or deletions were detected on the page; the Study Details and related sections appear unchanged from the previous version.SummaryDifference0.3%

- Check83 days agoChange Detected- Added a government funding notice affecting operation status and processing of transactions, plus a link to operating status information. - Updated version from v3.1.0 to v3.2.0. - Removed the old v3.1.0 revision tag.SummaryDifference2%

- Check90 days agoChange Detected- Updated version from v3.0.2 to v3.1.0. - No other content changes detected.SummaryDifference0.1%

Stay in the know with updates to Efgartigimod SC in Bullous Pemphigoid: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Efgartigimod SC in Bullous Pemphigoid: Clinical Trial page.